Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purposes of this project are to examine the feasibility, safety, tolerability and
clinical effect of low-dose buprenorphine as a novel treatment for late-life
treatment-resistant depression and to develop preliminary data about mechanism of action.